Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02686112
Other study ID # BNZ-0043-14
Secondary ID
Status Completed
Phase N/A
First received January 28, 2016
Last updated February 15, 2016
Start date January 2007
Est. completion date January 2016

Study information

Verified date February 2016
Source Bnai Zion Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.


Description:

the study is following woman retrospectively through their pregnancy from the first trimester troughout delivery .

we will measure the relation between first and/or second trimester bleeding ( threatend abortion ) and pregnancy outcome ( as written below ) - maternal and neonatal .


Recruitment information / eligibility

Status Completed
Enrollment 3000
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Women who attended the Emergency department with vaginal bleeding and/or abdominal pain and were on their 20th week of pregnancy or less.

Exclusion Criteria:

- Women with any background that can explain vaginal bleeding or any other circumstance that can explain it.

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Bnai Zion Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal and neonatal outcome in pregnancies with 1st and 2nd trimester bleeding by using our data in the past 7 years we will examine retrospectively cases of patients from their first admission due to vaginal bleeding throgh their pregnancy and labor .
the mesearment will include : Intra uterine growth retardation , Antepartum hemorrhage, premature rupture of membrane, Intra uterine fetal death , Preterm delivery, Apgar less than 7, Congenital malformation, Mode of delivery - vaginal delivery vs. cesarean section
9 months No
See also
  Status Clinical Trial Phase
Completed NCT02420769 - Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion N/A
Withdrawn NCT01501890 - Progesterone for First Trimester Vaginal Bleeding N/A
Completed NCT03930212 - Progesterone Supplementation in Threatened Abortion Phase 4
Completed NCT04788108 - Oral Progesterone for Prevention of Miscarriage in Threatened Abortion Phase 4